Related Experiment Video
Updated: Feb 20, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
LDL receptor affects the skeletal muscle and bone microstructure of female mouse through the Wnt/β-catenin signaling
Yue Hu1, Huiling Liu1,2, Chaoyue Zhao1
1School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, 533000, Guangxi, China.
Objective:
Osteosarcopenia, a composite disorder of age-related sarcopenia and osteoporosis, currently lacks targeted therapeutic interventions. We hypothesized that skeletal muscle-specific LDLR knockdown could reverse musculoskeletal functional decline via the Wnt/β-catenin signaling pathway.
Methods:
19-month-old female C57BL/6J mice were divided into elderly control (E-Con), elderly AAV vector-only (E-KD-C), and elderly LDLR knockdown (E-KD) groups, with an additional 3-month-old young control (Y-Con) group. Each group n = 6. After 8 weeks, the following parameters were assessed: grip strength, muscle histology (H&E staining, Goldner staining), bone microarchitecture (micro-CT scanning), and Wnt pathway components (RT-qPCR/Western blot).
Results:
Compared to Y-Con, Aged mice exhibited severe muscle atrophy (grip strength decline) and trabecular bone loss. LDLR knockdown in E-KD mice significantly enhanced grip strength and upregulated MYF5 and MYH2 expression. Furthermore, this intervention improved trabecular parameters (including bone volume BV, bone surface BS, and trabecular thickness Tb.Th) and activated the β-catenin signaling pathway through post-transcriptional regulation of FZD7 and LRP5.
Conclusion:
Skeletal muscle LDLR knockdown improves sarcopenia by reactivating the Wnt/β-catenin signaling pathway, providing a potential therapeutic target for musculoskeletal aging.
Insights
Targeting LDLR knockdown in skeletal muscle can reverse age-related muscle loss and bone density decline by activating the Wnt/β-catenin pathway, offering a new therapeutic strategy for osteosarcopenia.
Area of Science:
- Biomedical Science
- Aging Research
- Musculoskeletal Biology
Background:
- Osteosarcopenia, a dual condition of age-related sarcopenia and osteoporosis, lacks effective treatments.
- Aging leads to significant decline in muscle mass, strength, and bone integrity.
Purpose of the Study:
- To investigate if skeletal muscle-specific LDLR knockdown can reverse functional decline in osteosarcopenia.
- To explore the role of the Wnt/β-catenin signaling pathway in this process.
Main Methods:
- Elderly mice underwent LDLR knockdown in skeletal muscle.
- Assessed grip strength, muscle histology, bone microarchitecture via micro-CT, and Wnt pathway components.
- Utilized RT-qPCR and Western blot for pathway analysis.
Main Results:
- LDLR knockdown significantly improved grip strength and upregulated key muscle proteins (MYF5, MYH2).
- Enhanced trabecular bone parameters, including bone volume and thickness.
- Activated the β-catenin signaling pathway, indicating therapeutic potential.
Conclusions:
- Skeletal muscle LDLR knockdown is a promising strategy to combat sarcopenia.
- Reactivation of the Wnt/β-catenin pathway is crucial for these improvements.
- This approach offers a potential therapeutic target for musculoskeletal aging.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

